News | Hemodynamic Support Devices | July 16, 2020

FDA Clears Data Streaming From the Impella Console to Allow Use of Artificial Intelligence Algorithms 

Abiomed said data streaming sets stage to further improve patient outcomes

The Abiomed Impella Connect allows data streaming from the Impella control consoles to the cloud, where the next step will be to apply predictive artificial intelligence (AI) algorithms.

Figure 1: The Abiomed Impella Connect allows data streaming from the Impella control consoles to the cloud, where the next step will be to apply predictive artificial intelligence (AI) algorithms.


July 16, 2020 – The U.S. Food and Drug Administration (FDA) approved one-way digital data streaming during patient support from Abiomed's Automated Impella Controller (AIC), the external console used with Impella heart pumps. The data streaming capability is facilitated through the Impella Connect interface, a HIPAA-compliant, cloud-based remote monitoring platform that is currently installed at more than 200 hospitals. The approval means console data could be streamed live via Impella Connect to a secure server where artificial intelligence (AI) could provide predictive clinical information to the patient’s physician. 

As an example of how this technology might be used in future clinical practice, Abiomed has already trained an AI algorithm to predict the next five minutes of a patient’s arterial pressure based only on the prior five minutes of console data. (See Figure 1) Abiomed has also developed AI algorithms to predict other parameters, such as stroke volume, left ventricular pressure and cardiac output. The AI algorithms are not yet cleared or approved for patient use. Once fully developed, the vendor will be submitted it for regulatory review.

Predictive analytics are possible by integrating Impella clinical study data with Impella console data from thousands of cases and training artificial intelligence networks on the co-registered data. AI networks could then receive and analyze console data in real-time and send patient-specific predictions to that patient’s medical provider. (See Figure 2)

Figure 2: Six cases of machine learning using Impella Console data to predict patient arterial pressures over the next five minutes.

Figure 2: Six cases of machine learning using Impella Console data to predict patient arterial pressures over the next five minutes.

“Artificial intelligence networks, properly trained using large volumes of streaming data, can be powerful tools to aid in clinical decision-making,” said Chuck Simonton, M.D., Abiomed’s chief medical officer. “One day, using artificial intelligence, physicians may be able to confidently predict a patient’s future hemodynamics. That would make clinical decision-making more efficient and improve patient outcomes.”

Abiomed is also studying artificial intelligence to make more holistic predictions, such as the probability a patient will recover his or her native heart function. This information could help medical providers determine if an alternative course of action is needed.

More information on the future direction of Impella technology, including the application of artificial intelligence, is available in this online presentation.

For more information: www.impella.com
 


Related Content

News | Artificial Intelligence

May 30, 2023 — Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial ...

Home May 30, 2023
Home
News | Artificial Intelligence

May 19, 2023 — Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine ...

Home May 19, 2023
Home
News | Artificial Intelligence

May 9, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the ...

Home May 09, 2023
Home
News | Artificial Intelligence

May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or ...

Home May 04, 2023
Home
News | Artificial Intelligence

May 2, 2023 — Ambiq, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in ...

Home May 02, 2023
Home
News | Artificial Intelligence

April 26, 2023 —Ascend Cardiovascular, a leader in cardiovascular structured reporting and workflow solutions is ...

Home April 26, 2023
Home
Videos | Artificial Intelligence

Successfully creating and implementing artificial intelligence (AI) and analytic solutions in general requires a number ...

Home April 26, 2023
Home
Videos | Artificial Intelligence

With the help of artificial intelligence, cutting-edge technology is being developed that will help improve patient ...

Home April 25, 2023
Home
News | Artificial Intelligence

April 18, 2023 — HeartFlow, Inc. announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT ...

Home April 18, 2023
Home
News | Artificial Intelligence

April 17, 2023 — GE HealthCare, a leader in health technology, will showcase its growing portfolio of digital platforms ...

Home April 17, 2023
Home
Subscribe Now